FDA Clearance Tracker · K240254
Blood Pressure Monitor (TMB-2296-BT)
Last checked: Nov 20, 2026Latest source record: May 31, 2024 (this decision)Source: openFDAMethods & limitations
Decided
May 31, 2024
Substantially Equivalent
Time to decision
121 days
Received Jan 31, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K240254
- Device name
- Blood Pressure Monitor (TMB-2296-BT)
- Applicant location
- Zhongshan, CN
- Received
- Jan 31, 2024
- Decided
- May 31, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1130
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DXN. The earliest in FDA's data is K760930, decided Nov 9, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K240254
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Guangdong Transtek Medical Electronics Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K243060 · Decided Jan 30, 2025 · 125 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
K241351 · Decided Aug 21, 2024 · 100 days after receipt
Device type: System, Measurement, Blood-Pressure, Non-Invasive (DXN) · Cardiology
K240832 · Decided Jun 7, 2024 · 73 days after receipt
Device type: System, Measurement, Blood-Pressure, Non-Invasive (DXN) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.